Literature DB >> 30836137

Base editing the mammalian genome.

Emma M Schatoff1, Maria Paz Zafra2, Lukas E Dow3.   

Abstract

Base editing is a powerful technology that enables programmable conversion of single nucleotides in the mammalian genome. Base editors consist of a partially active Cas9 nuclease (Cas9D10A) tethered to a natural or synthetic DNA modifying enzyme. Though only recently described, BE has already shown enormous potential for basic and translational research, allowing the creation or repair of disease alleles in a variety of cell types and model organisms. In the past 2 years, a vast array of new and modified base editor variants have been described, expanding the flexibility and usefulness of the approach. Though simple in concept, effective implementation of base editing requires an understanding of the advantages and limitations of each of these tools. Here, we provide an overview of the concepts of DNA base editing, and discuss the recent progress toward the development of optimized base editing systems for mammalian cells. In addition, we highlight key technical aspects of designing and executing BE experiments, and provide detailed experimental examples of successful base editing in cell lines and organoids to help guide the effective use of these tools for genome modification.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APOBEC; BE; Base editing; CRISPR

Mesh:

Substances:

Year:  2019        PMID: 30836137      PMCID: PMC6684841          DOI: 10.1016/j.ymeth.2019.02.022

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  34 in total

1.  Rapid and efficient one-step generation of paired gRNA CRISPR-Cas9 libraries.

Authors:  Joana A Vidigal; Andrea Ventura
Journal:  Nat Commun       Date:  2015-08-17       Impact factor: 14.919

2.  Engineered CRISPR-Cas9 nucleases with altered PAM specificities.

Authors:  Benjamin P Kleinstiver; Michelle S Prew; Shengdar Q Tsai; Ved V Topkar; Nhu T Nguyen; Zongli Zheng; Andrew P W Gonzales; Zhuyun Li; Randall T Peterson; Jing-Ruey Joanna Yeh; Martin J Aryee; J Keith Joung
Journal:  Nature       Date:  2015-06-22       Impact factor: 49.962

3.  CRISPR-mediated direct mutation of cancer genes in the mouse liver.

Authors:  Wen Xue; Sidi Chen; Hao Yin; Tuomas Tammela; Thales Papagiannakopoulos; Nikhil S Joshi; Wenxin Cai; Gillian Yang; Roderick Bronson; Denise G Crowley; Feng Zhang; Daniel G Anderson; Phillip A Sharp; Tyler Jacks
Journal:  Nature       Date:  2014-08-06       Impact factor: 49.962

4.  In vivo base editing of post-mitotic sensory cells.

Authors:  Wei-Hsi Yeh; Hao Chiang; Holly A Rees; Albert S B Edge; David R Liu
Journal:  Nat Commun       Date:  2018-06-05       Impact factor: 14.919

5.  Treatment of a metabolic liver disease by in vivo genome base editing in adult mice.

Authors:  Lukas Villiger; Hiu Man Grisch-Chan; Helen Lindsay; Femke Ringnalda; Chiara B Pogliano; Gabriella Allegri; Ralph Fingerhut; Johannes Häberle; Joao Matos; Mark D Robinson; Beat Thöny; Gerald Schwank
Journal:  Nat Med       Date:  2018-10-08       Impact factor: 53.440

6.  Isolation, Culture, and Maintenance of Mouse Intestinal Stem Cells.

Authors:  Kevin P O'Rourke; Sarah Ackerman; Lukas E Dow; Scott W Lowe
Journal:  Bio Protoc       Date:  2016-02-20

7.  Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing.

Authors:  Zhen Liu; Zongyang Lu; Guang Yang; Shisheng Huang; Guanglei Li; Songjie Feng; Yajing Liu; Jianan Li; Wenxia Yu; Yu Zhang; Jia Chen; Qiang Sun; Xingxu Huang
Journal:  Nat Commun       Date:  2018-06-14       Impact factor: 14.919

8.  Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.

Authors:  Johnny H Hu; Shannon M Miller; Maarten H Geurts; Weixin Tang; Liwei Chen; Ning Sun; Christina M Zeina; Xue Gao; Holly A Rees; Zhi Lin; David R Liu
Journal:  Nature       Date:  2018-02-28       Impact factor: 49.962

9.  A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells.

Authors:  Christopher A Vakulskas; Daniel P Dever; Garrett R Rettig; Rolf Turk; Ashley M Jacobi; Michael A Collingwood; Nicole M Bode; Matthew S McNeill; Shuqi Yan; Joab Camarena; Ciaran M Lee; So Hyun Park; Volker Wiebking; Rasmus O Bak; Natalia Gomez-Ospina; Mara Pavel-Dinu; Wenchao Sun; Gang Bao; Matthew H Porteus; Mark A Behlke
Journal:  Nat Med       Date:  2018-08-06       Impact factor: 53.440

10.  Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland.

Authors:  Stefano Annunziato; Sjors M Kas; Micha Nethe; Hatice Yücel; Jessica Del Bravo; Colin Pritchard; Rahmen Bin Ali; Bas van Gerwen; Bjørn Siteur; Anne Paulien Drenth; Eva Schut; Marieke van de Ven; Mirjam C Boelens; Sjoerd Klarenbeek; Ivo J Huijbers; Martine H van Miltenburg; Jos Jonkers
Journal:  Genes Dev       Date:  2016-06-15       Impact factor: 11.361

View more
  4 in total

Review 1.  Modeling Psychiatric Disorder Biology with Stem Cells.

Authors:  Debamitra Das; Kyra Feuer; Marah Wahbeh; Dimitrios Avramopoulos
Journal:  Curr Psychiatry Rep       Date:  2020-04-21       Impact factor: 5.285

2.  Distinct Colorectal Cancer-Associated APC Mutations Dictate Response to Tankyrase Inhibition.

Authors:  Emma M Schatoff; Sukanya Goswami; Maria Paz Zafra; Miguel Foronda; Michael Shusterman; Benjamin I Leach; Alyna Katti; Bianca J Diaz; Lukas E Dow
Journal:  Cancer Discov       Date:  2019-07-23       Impact factor: 39.397

3.  Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing.

Authors:  Yu-Chan Yang; Yu-Hsiang Chen; Jia-Horng Kao; Chi Ching; I-Jung Liu; Chih-Chiang Wang; Cheng-Hsueh Tsai; Fang-Yi Wu; Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen; Hung-Chih Yang
Journal:  Mol Ther Nucleic Acids       Date:  2020-03-19       Impact factor: 8.886

4.  Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis.

Authors:  Josef Leibold; Marcus Ruscetti; Zhen Cao; Yu-Jui Ho; Timour Baslan; Min Zou; Wassim Abida; Judith Feucht; Teng Han; Francisco M Barriga; Kaloyan M Tsanov; Leah Zamechek; Amanda Kulick; Corina Amor; Sha Tian; Katarzyna Rybczyk; Nelson R Salgado; Francisco J Sánchez-Rivera; Philip A Watson; Elisa de Stanchina; John E Wilkinson; Lukas E Dow; Cory Abate-Shen; Charles L Sawyers; Scott W Lowe
Journal:  Cancer Discov       Date:  2020-05-06       Impact factor: 38.272

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.